Germany: MLL appoints Goldman Sachs for sale

The MLL team

The shakeout in the European diagnostics sector continues with the sale of diagnostics firm Munich Leukemia Laboratory (MLL) in the hands of Goldman Sachs. Co-founded by Claudia Haferlach and Torsten Haferlach in 2005, MLL is a diagnostics and research institution which is looking for a cure for leukaemia and lymphoma. MLL uses molecular and IT-supported…

You must be a HMI Subscriber to view this content.

Subscribe Now »